•Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN
•Risk of symptomatic leishmaniasis in patients with inflammatory bowel disease receiving biologic therapy in an endemic Mediterranean region: a population-based case-control study
•Mortality, cardiovascular disease, and cancer in coeliac disease and dermatitis herpetiformis: a matched cohort study
•From dysbiosis to precision medicine: targeting the microbial-metabolic axis in IBD management
•Dual Targeted Therapy With Risankizumab and Upadacitinib in Refractory Ulcerative Colitis
